Journal for ImmunoTherapy of Cancer (Nov 2023)

1147-A TNRX-257, a multifunctional LAG3 antagonist and conditional IL2Rϒ/ß partial agonist, is a novel immune stimulant with high dose tolerability in non-human primates

  • Rajesh Sharma,
  • Margaret Karow,
  • Stephen Demarest,
  • Natasha Del Cid,
  • Jianying Dong,
  • Christina Carnevale,
  • Christen Buetz,
  • Glenn Capodagli,
  • Jayd Hannah,
  • Pricilla Walter

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1147-A
Journal volume & issue
Vol. 11, no. Suppl 2

Abstract

Read online

No abstracts available.